Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can immunotherapy stop colorectal Cancer's return?

NCT ID NCT07058012

Recruiting now Disease control Sponsor: NSABP Foundation Inc Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests if immunotherapy drugs (cemiplimab, fianlimab, and REGN7075) can clear leftover cancer DNA in the blood of colorectal cancer patients after surgery and chemotherapy. The goal is to delay or prevent the cancer from coming back. About 79 adults with stage II/III colorectal cancer who still have cancer DNA in their blood will participate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLO-RECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colonic neoplasm colorectal adenocarcinoma colorectal cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLO-RECTAL CANCER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Allegheny General Hospital

    RECRUITING

    Pittsburgh, Pennsylvania, 15212, United States

  • Ballad Health Cancer Center - Kingsport

    RECRUITING

    Kingsport, Tennessee, 37660, United States

  • Bon Secours St. Francis Medical Center

    RECRUITING

    Midlothian, Virginia, 23114, United States

  • First Health of the Carolinas

    RECRUITING

    Pinehurst, North Carolina, 28374, United States

  • Missouri Baptist

    RECRUITING

    St Louis, Missouri, 63131, United States

  • University of Florida

    RECRUITING

    Gainesville, Florida, 32611, United States

  • University of Iowa - Holden Comprehensive Cancer Center

    RECRUITING

    Iowa City, Iowa, 52242, United States

  • University of Kansas Cancer Center

    RECRUITING

    Kansas City, Kansas, 66160, United States

  • Virginia Commonwealth University - Massey

    RECRUITING

    Richmond, Virginia, 23298, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.